
-
Denmark's Rune calls for heat rule at Shanghai Masters
-
Japanese football official sentenced for viewing child sexual abuse images
-
Stocks, gold steady amid political upheaval
-
'Veggie burgers' face grilling in EU parliament
-
Trio wins physics Nobel for quantum mechanical tunnelling
-
Two years after Hamas attack, Israelis mourn at Nova massacre site
-
German factory orders drop in new blow to Merz
-
Man City star Stones considered retiring after injury woes
-
Kane could extend Bayern stay as interest in Premier League cools
-
Renewables overtake coal but growth slows: reports
-
OpenAI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Extreme rains hit India's premier Darjeeling tea estates
-
Raducanu retires from opening match in Wuhan heat with dizziness
-
UK's Starmer condemns pro-Palestinian protests on Oct 7 anniversary
-
Tokyo stocks hit new record as markets extend global rally
-
Japan's Takaichi eyes expanding coalition, reports say
-
Canadian PM to visit White House to talk tariffs
-
Indonesia school collapse toll hits 67 as search ends
-
Dodgers hold off Phillies, Brewers on the brink
-
Lawrence sparks Jaguars over Chiefs in NFL thriller
-
EU channels Trump with tariffs to shield steel sector
-
Labuschagne out as Renshaw returns to Australia squad for India ODIs
-
Open AI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Tokyo stocks hit new record as Asian markets extend global rally
-
Computer advances and 'invisibility cloak' vie for physics Nobel
-
Nobel literature buzz tips Swiss postmodernist, Australians for prize
-
Dodgers hold off Phillies to win MLB playoff thriller
-
China exiles in Thailand lose hope, fearing Beijing's long reach
-
Israel marks October 7 anniversary as talks held to end Gaza war
-
Indians lead drop in US university visas
-
Colombia's armed groups 'expanding,' warns watchdog
-
Shhhh! California bans noisy TV commercials
-
Jericho Energy Ventures and Smartkem Sign Letter of Intent to Create U.S.-Owned, Nasdaq-Listed AI-Focused Infrastructure Company
-
Medical Care Technologies (OTC Pink:MDCE) Outlines Regulatory Roadmap: Dividing AI Health Platform Into Clinical and Consumer Divisions
-
Lithium Corporation Clarifies Corporate Identity Following Rare Earths Exploration Milestone
-
SMX Brings Compliance Into High-Fashion Through Game-Changing CETI Collaboration (NASDAQ:SMX)
-
Art's Way Reports Improved Results With Modular Buildings Growth Offsetting Ag Market Challenges
-
Konica Minolta Unleashes Comic Book Magic at PRINTING United Expo
-
Inovatec to Showcase Industry-Leading Funding Automation Technology at Auto Finance Summit 2025
-
IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease
-
American Resources Corporation's ReElement Technologies Advances as Finalist for National Science Foundation Award as Part of the Critical Materials Crossroads Consortium
-
Green Rain Energy Holdings Inc. (OTCID:$GREH) Integrates EV Infrastructure at 8757 Rio San Diego Drive with Major SDG&E Utility Upgrade
-
New to The Street Announces 12-Month National Media Partnership with Stardust Power (NASDAQ: SDST)
-
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
-
Leeward Group Expands Offering with Launch of Leeward Trust
-
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
-
Angkor Resources Completes First Onshore Seismic Program in Cambodia; Vanderbilt Report Publishes Coverage
-
ClearSign Secures 32-Burner Engineering Order from Global Supermajor
-
KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility
-
Water Tower Research Highlights Ainos' Transition to Technology Company Following GICS Reclassification

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential
30,000 BUZZ BOMB™ sample packs of four 50mg stick packs in each flavor distributed to convention attendees
Well-known fitness instructors, fitness celebrities, athletes, and influencers along with thousands of fitness enthusiasts and consumers sampled BUZZ BOMB™'s four bold flavors
As part of its launch, Aspire plans on partnering with well-known athletes and influencers across fitness training and endurance sports to accelerate consumer awareness and uptake
BUZZ BOMB™ is available for purchase at buzzbomb.buzz, the Company's new E-commerce website
ESTERO, FL / ACCESS Newswire / August 13, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced the successful launch and distribution of over 30,000 BUZZ BOMB™ sample four-packs, its newsublingual pre-workout supplement, at FitCon and FitExpo, held August 1-3, in Salt Lake City and Anaheim, with an estimated combined attendance in excess of 70,000 people.
BUZZ BOMB™, featuring 50mg of caffeine and offered in four flavors (Tropical Fruit, Mixed Berry, Peach Mango, and Coffee Mocha), provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike most pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB™ is sprinkled under the tongue right before or during a workout for immediate effect via direct delivery to the bloodstream.
BUZZ BOMB™ FitExpo Launch
Click here for BUZZ BOMB FitExpo Convention August 2-3, 2025 Video
BUZZ BOMB™ Testimonial from Leading Figures in the Fitness World
Bobby Maximus is a UFC fighter, Ju Jitsu Masters World Champion and fitness trainer. He has broken multiple power-endurance world records and is recognized as a leading figure in the fitness world. He starred in the recent feature film "Kill Shot" and is a best-selling Men's Health author and a regular contributor to "Men's Health" magazine (https://www.menshealth.com/author/214988/bobby-maximus/).
"In just about a minute, it feels like I drank a pre-workout 20 minutes ago."
"The taste… phenomenal! I really like that."
"I work out 2-3 times a day. One of the most inconvenient things is trying to time your pre workout drink 30 minutes before your workout. "
When I have a short window, I don't want to wait 30 minutes until it kicks in. The ability to just 'dump and go' with Buzz Bomb, is powerful. It's the convenience factor!
"I love the idea behind it! It helps me keep my caffeine intake down. Especially when you train 2 to 3 times a day."
"You cannot find another pre work with 50 mgs of caffeine… and it works! I love it!"
Brandon "MidWest Kong" Copeland (pictured above, third to the right) embodies the strength of a champion and the heart of a hero. A Brazilian Jiu-jitsu Black Belt, Copeland dominated the Mixed Martial Arts scene from 2005 to 2014, showcasing tenacity and skill. Initiating the "I Stopped The Bully" campaign in 2011, he became a beacon against bullying, inspiring youth across schools and detention centers. Copeland excelled in the fitness industry, breaking records like bench pressing 225 pounds 81 consecutive times. A published children's book author, he spreads messages of hope and community.
"I took the product! Let me say thank God! No heart flutter, no itchy sensation, no crash! I don't need the hard stuff anymore…feels absolutely great! I had a great workout as well!"
Commenting on the BUZZ BOMB™ launch, Kraig Higginson, Interim Chief Executive Officer of Aspire, said, "The launch and consumer response to BUZZ BOMB™ at two of the major fitness conventions, from booth activity, product sampling, feedback, interest from fitness experts and influencers, and potential licensing partners, exceeded all of our high expectations."
Higginson added, "With BUZZ BOMB™, we're raising the bar for ease of use, performance and value in the multi-billion-dollar caffeine category. We focused on creating a formula that is fast-absorbing and built for athletes, fitness enthusiasts and consumers who demand clean, effective fuel without unnecessary fillers or compromise. With online sales commencing August 1, we are now focused on increasing our marketing, expanding our third-party manufacturing capabilities, and preparing for further discussions with potential licensing partners in the nutritional and supplement space that can help us drive increased consumer awareness and accelerate our revenue potential for BUZZ BOMB™."
Consumers can purchase BUZZ BOMB™ online at buzzbomb.buzz
BUZZ BOMB™ Pre-workout Benefits:
Speed - works nearly immediately (less than 2 minutes) vs. 20-30 minutes
Convenience - easy to use single-use packets vs. mixing and measuring for beverages
Energy management - use as needed to precisely manage caffeine intake (50mg increments)
Single Safe Active Ingredient - well-known benefits and use of caffeine
A clean manageable Energy Boost
Low manufacturing & packaging costs - competitive pricing with high margin potential


Aspire's BUZZ BOMB™ - Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market.
About Aspire Biopharma, Inc.
Headquartered in Estero, Fl., Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit www.aspirebiolabs.com.
Safe Harbor Statement
Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
H.E.Young--AMWN